Modello Xenotrapianto eterogeneo derivato dal paziente del cancro pancreatico utilizzando larve di pesce zebra come ospiti per la valutazione comparativa del farmaco

Overview

This protocol describes a virus-based dual fluorescence-labeled tumor xenograft model using larval zebrafish as hosts. This model mimics the pancreatic cancer microenvironment in vivo, providing a precise tool for assessing drug responses in personalized zPDX models.

Key Study Components

Area of Science

• Neuroscience
• Oncology
• Pharmacology

Background

• Larval zebrafish can mimic human tissue composition.
• The model enhances consistency in drug response analysis.
• Fluorescent labeling allows real-time tracking of cellular compositions.
• Improved survival of human cells in zebrafish extends observation time.

Purpose of Study

• To develop a more accurate model for drug testing in pancreatic cancer.
• To facilitate personalized medicine approaches.
• To assess pre-clinical tumor drug responses effectively.

Methods Used

• Use of larval zebrafish as hosts for tumor xenografts.
• Application of dual fluorescence labeling techniques.
• Real-time tracing of cellular compositions during drug testing.
• Genetic modification of zebrafish to enhance human cell survival.

Main Results

• The model successfully mimics the pancreatic cancer microenvironment.
• Fluorescent labeling improved tracking of drug responses.
• Increased survival time of human cells was observed.
• The approach shows promise for personalized medicine applications.

Conclusions

• The zebrafish model is a valuable tool for cancer research.
• It enhances the assessment of drug efficacy in personalized treatments.
• Future studies can build on this model for further advancements.

Frequently Asked Questions